FDA Drug Application (202192) for JAKAFI by INCYTE CORP

Back to FDA Applications sponsored by INCYTE CORP

Application Number202192
Product Number001
FormTABLET;ORAL
DosageEQ 5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameJAKAFI
Active IngredientRUXOLITINIB PHOSPHATE



Back to FDA Applications sponsored by INCYTE CORP